These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12729672)

  • 1. Substituted bridged phenyl piperidines: orally active growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2003 May; 13(10):1817-20. PubMed ID: 12729672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue.
    Yang L; Morriello G; Patchett AA; Leung K; Jacks T; Cheng K; Schleim KD; Feeney W; Chan WW; Chiu SH; Smith RG
    J Med Chem; 1998 Jul; 41(14):2439-41. PubMed ID: 9651148
    [No Abstract]   [Full Text] [Related]  

  • 3. Highly potent growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3657-9. PubMed ID: 17482461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel orally active growth hormone secretagogues.
    Hansen TK; Ankersen M; Hansen BS; Raun K; Nielsen KK; Lau J; Peschke B; Lundt BF; Thøgersen H; Johansen NL; Madsen K; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3705-14. PubMed ID: 9733496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues.
    Barakat KJ; Cheng K; Chan WW; Butler BS; Jacks TM; Schleim KD; Hora DF; Hickey GJ; Smith RG; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1431-6. PubMed ID: 9871779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin.
    Carpino PA; Lefker BA; Toler SM; Pan LC; Hadcock JR; Cook ER; DiBrino JN; Campeta AM; DeNinno SL; Chidsey-Frink KL; Hada WA; Inthavongsay J; Mangano FM; Mullins MA; Nickerson DF; Ng O; Pirie CM; Ragan JA; Rose CR; Tess DA; Wright AS; Yu L; Zawistoski MP; DaSilva-Jardine PA; Wilson TC; Thompson DD
    Bioorg Med Chem; 2003 Feb; 11(4):581-90. PubMed ID: 12538023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent, orally bioavailable benzazepinone growth hormone secretagogue.
    DeVita RJ; Bochis R; Frontier AJ; Kotliar A; Fisher MH; Schoen WR; Wyvratt MJ; Cheng K; Chan WW; Butler B; Jacks TM; Hickey GJ; Schleim KD; Leung K; Chen Z; Chiu SL; Feeney WP; Cunningham PK; Smith RG
    J Med Chem; 1998 May; 41(10):1716-28. PubMed ID: 9572898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent 3-spiropiperidine growth hormone secretagogues.
    Yang L; Morriello G; Prendergast K; Cheng K; Jacks T; Chan WW; Schleim KD; Smith RG; Patchett AA
    Bioorg Med Chem Lett; 1998 Jan; 8(1):107-12. PubMed ID: 9925440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxindole derivatives as orally active potent growth hormone secretagogues.
    Tokunaga T; Hume WE; Umezome T; Okazaki K; Ueki Y; Kumagai K; Hourai S; Nagamine J; Seki H; Taiji M; Noguchi H; Nagata R
    J Med Chem; 2001 Dec; 44(26):4641-9. PubMed ID: 11741481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New highly potent dipeptidic growth hormone secretagogues with low molecular weight.
    Peschke B; Ankersen M; Hansen TK; Hansen BS; Lau J; Nielsen KK; Raun K
    Eur J Med Chem; 2000 Jun; 35(6):599-618. PubMed ID: 10906412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.
    Hansen TK; Ankersen M; Raun K; Hansen BS
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1915-8. PubMed ID: 11459660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds.
    Shen DM; Shu M; Willoughby CA; Shah S; Lynch CL; Hale JJ; Mills SG; Chapman KT; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Lyons K; Pivnichny JV; Kwei GY; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller MD; Emini EA
    Bioorg Med Chem Lett; 2004 Feb; 14(4):941-5. PubMed ID: 15012998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazole-derived potent, highly bioavailable short duration growth hormone secretagogues.
    Yang L; Morriello G; Leung K; Jacks T; Cheng K; Schleim KD; Smith R; Patchett AA
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1761-6. PubMed ID: 10406638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Pyridylcyanomethyl)piperazines as orally active PAF antagonists.
    Carceller E; Almansa C; Merlos M; Giral M; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1992 Oct; 35(22):4118-34. PubMed ID: 1433215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and biological characterization of capromorelin analogues with extended half-lives.
    Carpino PA; Lefker BA; Toler SM; Pan LC; Hadcock JR; Murray MC; Cook ER; DiBrino JN; DeNinno SL; Chidsey-Frink KL; Hada WA; Inthavongsay J; Lewis SK; Mangano FM; Mullins MA; Nickerson DF; Ng O; Pirie CM; Ragan JA; Rose CR; Tess DA; Wright AS; Yu L; Zawistoski MP; Pettersen JC; DaSilva-Jardine PA; Wilson TC; Thompson DD
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3279-82. PubMed ID: 12392732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.
    Ankersen M; Johansen NL; Madsen K; Hansen BS; Raun K; Nielsen KK; Thogersen H; Hansen TK; Peschke B; Lau J; Lundt BF; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3699-704. PubMed ID: 9733495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.
    Li J; Chen SY; Murphy BJ; Flynn N; Seethala R; Slusarchyk D; Yan M; Sleph P; Zhang H; Humphreys WG; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4072-4. PubMed ID: 18554903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
    Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.